Jason Starr, DO
Hematology & Oncology · Jacksonville, FLNPI 1205090107
Payments from drug & device makers
Across 155 payments — averaging $7010.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$662K
- AstraZeneca$145K
- Amgen$74K
- Boehringer Ingelheim$45K
- Daiichi Sankyo Company LTD$33K
- Daiichi Sankyo Inc.$32K
- plus $95K from 22 others
What the payments were for
- Consulting fees$21,20070%
- Speaking & faculty fees$7,94826%
- Food & beverage$1,0764%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 3 | $662,291 |
| AstraZeneca | 3 | $145,482 |
| Amgen | 9 | $73,920 |
| Boehringer Ingelheim | 4 | $45,030 |
| Daiichi Sankyo Company LTD | 3 | $33,099 |
| Daiichi Sankyo Inc. | 4 | $31,670 |
| Beigene, Ltd. | 8 | $22,170 |
| Macrogenics, Inc. | 4 | $18,900 |
| Incyte Corporation | 57 | $9,685 |
| Array Biopharma Inc | 2 | $9,130 |
| Pfizer | 1 | $5,449 |
| Ipsen Biopharmaceuticals, Inc | 6 | $4,925 |
| Taiho Oncology, Inc. | 2 | $4,338 |
| Exelixis Inc. | 6 | $4,004 |
| Tersera Therapeutics LLC | 5 | $3,974 |
| Jazz Pharmaceuticals Inc. | 1 | $3,296 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $2,655 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 18 | $1,945 |
| Advanced Accelerator Applications | 1 | $1,485 |
| Novartis | 3 | $1,425 |
| Boehringer Ingelheim International GmbH | 2 | $1,425 |
| Genentech USA, Inc. | 1 | $125 |
| Lexicon Pharmaceuticals, Inc. | 3 | $107 |
| Bayer | 3 | $80 |
| Foundation Medicine, Inc. | 2 | $28 |
| Tempus AI, Inc | 1 | $28 |
| Deciphera Pharmaceuticals Inc. | 1 | $25 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,086,702 in reported general payments places this provider in the 85th percentile of 694 hematology & oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TibsovoIvosidenib | 11 | $342,815 |
| Oxycodone Hcl | 20 | $372 |
| Spironolactone | 15 | $101 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Jacksonville
- Steven AttiaJacksonville$13.9M
- Sikander AilawadhiJacksonville$9.8M
- Vamsidhar VelchetiJacksonville$8.2M
- Asher Chanan KhanJacksonville$5.8M
- Yanyan LouJacksonville$4.8M
- Arnab BasuJacksonville$4.6M
- James ForanJacksonville$4.6M
- Jennifer CrozierJacksonville$3.5M
- Ayed AyedJacksonville$3.4M
- Saranya ChumsriJacksonville$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.